NO-1886
CAS: 133208-93-2
Ref. 3D-IFA20893
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
NO-1886
Synonyme:
- 4-[N-(4-Bromo-2-cyanophenyl)carbamoyl]benzylphosphonic acid diethyl ester
- Diethyl [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]phosphonate
- Diethyl {4-[(4-Bromo-2-Cyanophenyl)Carbamoyl]Benzyl}Phosphonate
- Ibrolipim
- No-1886
- Opf-009
- Phosphonic acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, diethyl ester
Beschreibung:
NO-1886 is a novel small molecule that inhibits the activity of growth factor-β1 and is used to treat metabolic disorders, such as bowel disease. It has been shown to increase the expression of lipoprotein lipase in human serum and adipose tissue. NO-1886 also reduces hepatic steatosis and tubulointerstitial injury by inhibiting lipolysis, which prevents the release of fatty acids from adipose tissue into the blood stream. This drug is being developed for clinical trials for the treatment of atherosclerotic lesions.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
451.25 g/mol
Formel:
C19H20BrN2O4P
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
